{
      "full_text_status": "none",
      "type": "article",
      "id_number": "oai:ojs.pkp.sfu.ca:article/16816",
      "date": "2026-02-23",
      "uri": "https://arxiv.universalpublishings.com/id/eprint/71112",
      "date_type": "published",
      "metadata_visibility": "show",
      "ispublished": "pub",
      "note": "Imported from Universal Publishings (OAI id oai:ojs.pkp.sfu.ca:article/16816)",
      "userid": 1,
      "official_url": "https://universalpublishings.com/index.php/itfttdm/article/view/16816",
      "subjects": [
        "arterial hypertension, hypotensive agents, vasopressors, inotropic drugs, RAAS, beta-blocker, ACE inhibitor, ARB, calcium channel blocker, safety and monitoring"
      ],
      "publisher": "\"XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TA\u02bcLIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR\" nomli respublika ilmiy-amaliy konferensiyasi",
      "rev_number": 1,
      "datestamp": "2026-05-26 16:00:44",
      "abstract": "Arterial blood pressure is determined by cardiac output and peripheral vascular resistance; these parameters are finely regulated through the renin\u2013angiotensin\u2013aldosterone system, the sympathetic nervous system, renal sodium\u2013water handling, and endothelial mediators. For this reason, the pharmacology of hypotensive (blood-pressure\u2013lowering) and hypertensive (blood-pressure\u2013raising, pressor) agents cannot be reduced to the simple idea of \u201clowering or raising the number\u201d: such agents influence the heart, kidneys, brain, and peripheral vessels through different pathways and serve distinct goals in acute and chronic clinical settings",
      "status_changed": "2026-05-26 16:00:44",
      "title": "HYPOTENSIVE AND HYPERTENSIVE AGENTS: MECHANISMS, DOSE\u2013RESPONSE RELATIONSHIPS, CLINICAL USE, ADVERSE EFFECTS, AND SAFETY PRINCIPLES",
      "eprintid": 71112,
      "creators": [
        {
          "name": {
            "honourific": null,
            "given": "Amonov Botirali Baxrom",
            "family": "o\u2018g\u2018li",
            "lineage": null
          }
        },
        {
          "name": {
            "given": "Kibriyeva Maxfirat",
            "honourific": null,
            "family": "Abdurakhmonovna",
            "lineage": null
          }
        }
      ],
      "sword_depositor": 1,
      "dir": "disk0/00/07/11/12",
      "keywords": "arterial hypertension, hypotensive agents, vasopressors, inotropic drugs, RAAS, beta-blocker, ACE inhibitor, ARB, calcium channel blocker, safety and monitoring",
      "eprint_status": "archive",
      "lastmod": "2026-05-26 16:00:44",
      "publication": "XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TA\u02bcLIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR nomli respublika ilmiy-amaliy konferensiyasi"
    }